---
category: news
title: "AI microbiome firm Xbiome raises $20M+ to push candidates into clinic"
excerpt: "Shenzhen Xbiome Biotech Co. Ltd., an artificial intelligence (AI)-based microbiome drugmaker, raised more than $20 million in a series B+ round, Xbiome CEO Yan Tan told BioWorld, financing that will help the company launch its phase I trial next year."
publishedDateTime: 2020-12-01T22:42:00Z
originalUrl: "https://www.bioworld.com/articles/500800-ai-microbiome-firm-xbiome-raises-20m-to-push-candidates-into-clinic"
webUrl: "https://www.bioworld.com/articles/500800-ai-microbiome-firm-xbiome-raises-20m-to-push-candidates-into-clinic"
type: article
quality: 39
heat: 39
published: false

provider:
  name: BioWorld
  domain: bioworld.com

topics:
  - AI in Healthcare
  - AI

images:
  - url: "https://www.bioworld.com/ext/resources/Stock-images/Therapeutic-topics/Gastrointestinal/thumb/Gastrointestinal-microbiome.png?height=635&t=1586206918&width=1200"
    width: 650
    height: 487
    isCached: true

secured: "SmpRDD0bIhqSMj/CBCVzHKsOXw6sApW1IAVMZZAgkBJHs50a2yf9ZEPmo53IHaKQ3+mTBeFKJWG560eZ1LQkna72qHa8Fe399v7aaB+0yOiUS0LQNWJAHtLr9d/osIFQi09NWzP1ngQpxNY+pJFRkhQETj7DPa0ThPGV8gddODLGm6mCFsYLHs16+ncIxKzuEpuyD0A4TULIt+BR1sdp0gzoSTGKnNkXH3XLkAFzlRRm+54xkU9559YlkM4rTgj5UvJ3atnzMDYQa+eEQzDucAaol38MfpTb4bF6LvSu3kfdBj5uAERLqCAx8vnrumEuGQPels2PLJBetKlOXncutE3PXxy8NNzlSvEmAa6M8Hg=;Mf9xHoQY5Z/+hd8ZHY7+1g=="
---

